'Isolated DNA' Definition May Be Biggest Barrier to Summary Judgment at Anti-Gene Patenting Hearing

The ACLU, on behalf of plaintiffs in its anti-gene patenting case, filed a counterstatement on Jan. 20 against defendant Myriad Genetics' claims that isolated DNA molecules are patentable chemical compounds. In addition, several genetics experts have filed statements challenging many of Myriad's scientific claims.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.